http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6670325-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e53d73c05af44a1183ba2128357fa4ae |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 |
| filingDate | 2001-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed662a689dd93feb69880362bd3d2117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93615ce660ff8b51635afb94b929dc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9340444a80952666721a2aefb8a85555 |
| publicationDate | 2003-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6670325-B2 |
| titleOfInvention | Treatment of osteocarcinoma with alpha-1—antitrypsin or secretory leucocyte protease inhibitor |
| abstract | The present invention relates to the treatment of cancerous conditions in mammals by the administration to the site of disease compositions containing serine protease inhibitor. The cancerous conditions include osteocarcinomas, melanoma, Karopsi sarcoma and keratosis. The compositions are also useful to relieve the pain associated with the disease. |
| priorityDate | 2001-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.